| Product Code: ETC10070435 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Vietnam Chemotherapy-Induced Peripheral Neuropathy Market Overview |
3.1 Vietnam Country Macro Economic Indicators |
3.2 Vietnam Chemotherapy-Induced Peripheral Neuropathy Market Revenues & Volume, 2021 & 2031F |
3.3 Vietnam Chemotherapy-Induced Peripheral Neuropathy Market - Industry Life Cycle |
3.4 Vietnam Chemotherapy-Induced Peripheral Neuropathy Market - Porter's Five Forces |
3.5 Vietnam Chemotherapy-Induced Peripheral Neuropathy Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Vietnam Chemotherapy-Induced Peripheral Neuropathy Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Vietnam Chemotherapy-Induced Peripheral Neuropathy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidences of cancer and subsequent rise in chemotherapy treatments |
4.2.2 Growing awareness about chemotherapy-induced peripheral neuropathy among healthcare professionals and patients |
4.2.3 Advancements in healthcare infrastructure and technology in Vietnam |
4.3 Market Restraints |
4.3.1 High cost associated with the treatment of chemotherapy-induced peripheral neuropathy |
4.3.2 Limited availability of specialized healthcare professionals for managing chemotherapy-induced peripheral neuropathy in Vietnam |
5 Vietnam Chemotherapy-Induced Peripheral Neuropathy Market Trends |
6 Vietnam Chemotherapy-Induced Peripheral Neuropathy Market, By Types |
6.1 Vietnam Chemotherapy-Induced Peripheral Neuropathy Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Vietnam Chemotherapy-Induced Peripheral Neuropathy Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Vietnam Chemotherapy-Induced Peripheral Neuropathy Market Revenues & Volume, By Steroids, 2021- 2031F |
6.1.4 Vietnam Chemotherapy-Induced Peripheral Neuropathy Market Revenues & Volume, By Antidepressants, 2021- 2031F |
6.1.5 Vietnam Chemotherapy-Induced Peripheral Neuropathy Market Revenues & Volume, By Anti-Seizure, 2021- 2031F |
6.1.6 Vietnam Chemotherapy-Induced Peripheral Neuropathy Market Revenues & Volume, By Narcotics, 2021- 2031F |
6.2 Vietnam Chemotherapy-Induced Peripheral Neuropathy Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 Vietnam Chemotherapy-Induced Peripheral Neuropathy Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.2.3 Vietnam Chemotherapy-Induced Peripheral Neuropathy Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.2.4 Vietnam Chemotherapy-Induced Peripheral Neuropathy Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Vietnam Chemotherapy-Induced Peripheral Neuropathy Market Import-Export Trade Statistics |
7.1 Vietnam Chemotherapy-Induced Peripheral Neuropathy Market Export to Major Countries |
7.2 Vietnam Chemotherapy-Induced Peripheral Neuropathy Market Imports from Major Countries |
8 Vietnam Chemotherapy-Induced Peripheral Neuropathy Market Key Performance Indicators |
8.1 Patient-reported neuropathy symptoms improvement rates |
8.2 Number of hospitals/clinics offering specialized treatment for chemotherapy-induced peripheral neuropathy |
8.3 Research funding allocated for studying and developing new treatments for chemotherapy-induced peripheral neuropathy in Vietnam |
9 Vietnam Chemotherapy-Induced Peripheral Neuropathy Market - Opportunity Assessment |
9.1 Vietnam Chemotherapy-Induced Peripheral Neuropathy Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Vietnam Chemotherapy-Induced Peripheral Neuropathy Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Vietnam Chemotherapy-Induced Peripheral Neuropathy Market - Competitive Landscape |
10.1 Vietnam Chemotherapy-Induced Peripheral Neuropathy Market Revenue Share, By Companies, 2024 |
10.2 Vietnam Chemotherapy-Induced Peripheral Neuropathy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here